Bellerophon Therapeutics
Latest round
- Series A
Last raised
- Dec 2013
Total raised
- $80M
Investors
- 5
About Bellerophon Therapeutics
Bellerophon Therapeutics Inc.Founded in 2014 and headquartered in Warren, US, Bellerophon Therapeutics Inc. specializes in therapeutic solutions for respiratory conditions.00 mn. The firm has completed 8 deals to date.Bellerophon focuses on developing innovative therapeutic solutions aimed at addressing serious respiratory and cardiovascular diseases. Its core product offering includes proprietary drug delivery systems designed to enhance the efficacy and safety of existing treatments, targeting conditions such as pulmonary hypertension. The primary end users are patients, healthcare providers, and specialty pharmacies that facilitate access to these therapies.Bellerophon generates revenue through the commercialization of specialized therapeutic products, primarily engaging in B2B transactions with healthcare institutions and specialized distributors. Revenue is derived from long-term supply agreements and direct sales to hospitals and clinics, structured to meet the needs of healthcare providers.Bellerophon plans to expand its product offerings by designing and launching new therapeutic solutions targeting unmet medical needs in respiratory and cardiovascular diseases. The company aims to enter new geographic markets in Europe and expand its presence in North America by 2025.00 mn will be utilized to support these initiatives, including the potential launch of new products.
Who invested in Bellerophon Therapeutics
5 investors across 1 round
See all investors in Bellerophon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 26, 2013
Amount
$80M
Investors
Questions about Bellerophon Therapeutics
Who invested in Bellerophon Therapeutics?
Bellerophon Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bellerophon Therapeutics raised?
Bellerophon Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bellerophon Therapeutics last raise money?
Bellerophon Therapeutics's most recent round on record is a Series A, in Dec 2013.
What does Bellerophon Therapeutics do?
Bellerophon Therapeutics is a biotechnology company.
Where is Bellerophon Therapeutics headquartered?
Bellerophon Therapeutics is headquartered in Warren, US.
Which VCs invest in companies like Bellerophon Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Bellerophon Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Bellerophon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.